A new evidence‐based guideline for assessment and management of polycystic ovary syndrome
Authors: Helena J Teede, Robert J Norman and Rhonda M Garad
Published online: 1 April 2019
In reply
As a result of the evidence synthesis and the guideline, leading PCOS researchers and consumers identified the following priorities for PCOS research: biological origins, diagnosis accuracy, contemporary PCOS‐related genetics, prevalence across diverse population groups (with a focus on Indigenous people), economic and health impacts, psychological burden, effective translation and implementation approaches, infertility, pregnancy complications, perinatal outcomes, and follow‐up in children with PCOS. In addition, the robust evaluation framework underpinning the PCOS guideline provides implementation data to further guide research priorities.
We endorse calls for increased PCOS research funding to focus on gaps and priorities emerging from the evidence‐based guidelines. The successful international guideline development process has delivered a road map in which best practice research is characterised as consumer‐driven, global, collaborative, multidisciplinary and large scale, with outcomes that will drive equity, focus public policy, build health sector capacity and deliver effective research translation and impacts. It is time for research funding bodies to disincentivise competitive, small scale, monodisciplinary, siloed research, and to enable collaborative, impactful, strategic, prioritised research addressing clear gaps in areas of high disease burden, including PCOS.
Competing interests
We are co‐authors of the International Evidence‐based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
References
- Norman RJ, Teede HJ. A new evidence‐based guideline for assessment and management of polycystic ovary syndrome. Med J Aust 2018; 209: 299–300. https://www.mja.com.au/journal/2018/209/7/new-evidence-based-guideline-assessment-and-management-polycystic-ovary-syndrome
- Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2018; 89: 251–268.
Linked content
-
MJA Letter: A new evidence‐based guideline for assessment and management of polycystic ovary syndrome
-
MJA Editorial: A new evidence-based guideline for assessment and management of polycystic ovary syndrome
Getting on the Same Page: Why Australia Needs a National Maternity Early Warning System (MEWS) Chart
Briony A. Cutts, Lucy Bowyer, Nisha Khot, Sandra Lowe, Stefan C. Kane
Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments
Jessica Bennett, Jamie Bryant, Kade Booth, Michelle Kennedy
Interpreting Australian Stillbirth Rate Trends: Implications for Surveillance and Continuous Quality Improvement
Aleena M. Wojcieszek, Kirstine Sketcher-Baker, Christine Andrews, Michael Coory, Imogen Kettle, Melissa Malivoire, David Ellwood, Vicki Flenady
The clinical presentation, investigation, and management of women diagnosed with endometriosis in Australian general practices, 2011–2021: an open cohort study
Danielle Mazza, Kailash Thapaliya, Sharinne B Crawford, Alissia Hui, Maryam Moradi, Luke E Grzeskowiak
The early implementation phase of the Omega‐3 Test‐and‐Treat Program for reducing the risk of preterm birth, South Australia, 2021–22: an implementation evaluation study
Karen P Best, Celine Northcott, Lucy A Simmonds, Philippa Middleton, Lisa N Yelland, Vanessa Moffa, Khoa Lam, Penelope Coates, Cornelia Späth, Carol WK Siu, Karen Glover, Rhiannon Smith, Robert Gibson, Maria Makrides
Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021
Aaron E Boyce, Tony Caccetta, Jo‐Ann See, Rosemary L Nixon AM